Diabetes News Archive

New diabetes research provides more insight on how Type 2 Diabetes works.

SILVER SPRING, Md., June 28 (UPI) -- A U.S. study of more than 227,000 patients found those prescribed the diabetes drug Avandia had a higher risk of heart trouble and death, researchers said. United States - GlaxoSmithKline - Food and Drug Administration - Health - Journal of the American Medical Association

The Juvenile Diabetes Research Foundation Palmetto Chapter is hosting its annual Tee Up to Cure Diabetes Classic today at Wildewood Country Club.

WASHINGTON - PATIENTS taking the anti-diabetes drug Avandia may be at increased risk of cardiovascular ailments compared to those taking other drugs to treat diabetes, a US government study found on Monday. The analysis by the US Food and Drug Administration was in line with a spate of recent studies which have raised concern about the blockbuster medication, which also goes by the name ...

A new US study ties the controversial diabetes drug Avandia to a higher risk of heart problems, strokes and deaths in older adults.

Title: Diabetes Drug Avandia Ups Heart Risk, Reviews Conclude Category: Health News Created: 6/28/2010 8:10:00 AM Last Editorial Review: 6/28/2010

A new analysis affirms earlier data concluding that Avandia may raise the risk of heart attack, stroke and other complications in diabetes patients.

Seniors taking the Type 2 diabetes drug Avandia may be at increased risk of heart problems, strokes and death, according to research that adds to critics' calls to use an alternative treatment.

Ahead of FDA hearing, new report ties diabetes pill to more heart problems, deaths than rival Food and Drug Administration - Heart disease - Health - Diabetes - GlaxoSmithKline

A new study led by a federal drug safety expert ties the controversial diabetes drug Avandia to a higher risk of heart problems, strokes and deaths in older adults, and says it is more dangerous

A new study ties the controversial diabetes drug Avandia to a higher risk of heart problems, strokes and deaths in older adults.

Sanofi's study of diabetes patients using Lantus in combination with Apidra showed improved patient outcomes.

CHICAGO - A NEW study led by a federal drug safety expert ties the controversial diabetes drug Avandia to a higher risk of heart problems, strokes and deaths in older adults, and says it is more dangerous than a rival drug, Actos. The study, a huge review of records from the federal health care program for the elderly, comes two weeks ahead of a Food and Drug Administration hearing on Avandia's ...

An international team of scientists working on the largest study to date to look at DNA and type 2 diabetes say they have found 12 new gene links that offer important clues to how the chronic disease works.

CHICAGO (AP) A new study led by a federal drug safety expert ties the controversial diabetes drug Avandia to a higher...

A new study ties diabetes drug Avandia to a higher risk of heart problems, strokes and deaths in older adults.

A new study ties the controversial diabetes drug Avandia to a higher risk of heart problems, strokes and deaths

Two studies released on Monday reported serious heart risks with GlaxoSmithKline Plc diabetes pill Avandia as U.S. regulators decide whether the drug should stay on the market. GlaxoSmithKline - Diabetes mellitus - Health - United States - Diabetes

A commonly used diabetes drug increases the risk of stroke, heart disease, and death, according to a study released today in the Journal of the American Medical Association.

A new study led by a federal drug safety expert ties the controversial diabetes drug Avandia to a higher risk of heart problems, strokes and deaths in older adults, and says it is more dangerous than a rival drug, Actos.

Associated Press - June 28, 2010 10:14 AM ET CHICAGO (AP) - A new study ties the controversial diabetes drug Avandia to a higher risk of heart problems, strokes and deaths in older...

Use of a common diabetes drug associated with a 39 per cent increased risk of heart attack is not justified when other drugs offer the same benefit, researchers have concluded.

Use of a common diabetes drug associated with a 39 per cent increased risk of heart attack is not justified when other drugs offer the same benefit, researchers say.

The bad news: as obesity rises, so does diabetes, especially among minorities.

MONDAY, June 28 (HealthDay News) -- According to data pooled from several large clinical trials, the diabetes drug Avandia does raise the odds of having a heart attack, bolstering the argument that the drug's risks might outweigh its benefits in people with type 2 diabetes.

Two popular diabetes drugs do not increase the risk of acute pancreatitis, according to a study presented today at the American Diabetes Association's 70th Scientific Sessions.